Optimising a urinary extraction method for non-targeted GC-MS metabolomics.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
16 10 2023
16 10 2023
Historique:
received:
13
07
2023
accepted:
11
10
2023
medline:
23
10
2023
pubmed:
17
10
2023
entrez:
16
10
2023
Statut:
epublish
Résumé
Urine is ideal for non-targeted metabolomics, providing valuable insights into normal and pathological cellular processes. Optimal extraction is critical since non-targeted metabolomics aims to analyse various compound classes. Here, we optimised a low-volume urine preparation procedure for non-targeted GC-MS. Five extraction methods (four organic acid [OA] extraction variations and a "direct analysis" [DA] approach) were assessed based on repeatability, metabolome coverage, and metabolite recovery. The DA method exhibited superior repeatability, and achieved the highest metabolome coverage, detecting 91 unique metabolites from multiple compound classes comparatively. Conversely, OA methods may not be suitable for all non-targeted metabolomics applications due to their bias toward a specific compound class. In accordance, the OA methods demonstrated limitations, with lower compound recovery and a higher percentage of undetected compounds. The DA method was further improved by incorporating an additional drying step between two-step derivatization but did not benefit from urease sample pre-treatment. Overall, this study establishes an improved low-volume urine preparation approach for future non-targeted urine metabolomics applications using GC-MS. Our findings contribute to advancing the field of metabolomics and enable efficient, comprehensive analysis of urinary metabolites, which could facilitate more accurate disease diagnosis or biomarker discovery.
Identifiants
pubmed: 37845360
doi: 10.1038/s41598-023-44690-7
pii: 10.1038/s41598-023-44690-7
pmc: PMC10579216
doi:
Substances chimiques
Urease
EC 3.5.1.5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17591Informations de copyright
© 2023. Springer Nature Limited.
Références
EBioMedicine. 2018 May;31:157-165
pubmed: 29752217
Anal Chim Acta. 2009 Sep 28;651(1):75-80
pubmed: 19733738
J Sep Sci. 2020 Jan;43(1):202-225
pubmed: 31692234
Curr Protoc Mol Biol. 2016 Apr 01;114:30.4.1-30.4.32
pubmed: 27038389
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Aug 1;964:195-201
pubmed: 24480519
J Chromatogr A. 2021 Nov 22;1658:462590
pubmed: 34666271
Mitochondrion. 2019 Mar;45:38-45
pubmed: 29471047
Metabolomics. 2014 Oct 1;10(5):897-908
pubmed: 25254001
Brief Bioinform. 2006 Jun;7(2):128-39
pubmed: 16772266
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):191-201
pubmed: 18538643
Anal Biochem. 2007 Apr 15;363(2):185-95
pubmed: 17316536
Metabolomics. 2020 May 18;16(6):66
pubmed: 32419109
Nat Rev Drug Discov. 2002 Feb;1(2):153-61
pubmed: 12120097
PLoS One. 2020 Mar 17;15(3):e0230072
pubmed: 32182259
J Microbiol Methods. 2012 Nov;91(2):301-11
pubmed: 22982125
Metabolites. 2019 Apr 05;9(4):
pubmed: 30959834
BMC Med. 2016 Mar 23;14:53
pubmed: 27007773
Rapid Commun Mass Spectrom. 2008 Oct;22(19):2984-92
pubmed: 18763274
Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):263-9
pubmed: 22436749
Phys Biol. 2008 Feb 20;5(1):011001
pubmed: 18367780
Clin Chim Acta. 1964 Oct;10:352-9
pubmed: 14219580
Molecules. 2020 Aug 11;25(16):
pubmed: 32796601
Anal Chem. 2000 Aug 1;72(15):3573-80
pubmed: 10952545
J Inherit Metab Dis. 2018 May;41(3):355-366
pubmed: 29536203
Nat Protoc. 2011 Sep 08;6(10):1483-99
pubmed: 21959233
Br J Clin Pharmacol. 2013 Mar;75(3):619-29
pubmed: 22348240
Clin Chim Acta. 2018 Oct;485:236-242
pubmed: 30008426